VANCOUVER,
Jan. 15, 2019
/CNW/ - INVICTUS MD STRATEGIES CORP.
("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA:
8IS1) is pleased to announce that the Company's
Board of Directors (the "Board") has approved the appointment of
Keith Stein, Counsel at Dentons
Canada LLP ("Dentons"), to serve on the Board effective
January 11, 2019. The new appointment
follows the resignations of Trevor
Dixon, President and Director of Invictus since April 25, 2017, and Josef
Hocher, member of the Board since June 26, 2017. Mr. Dixon will remain as President
and Director of the Company's wholly-owned subsidiary Acreage
Pharms Ltd ("Acreage Pharms"). George E. Kveton, CEO of Invictus
will assume the role of President of the Company.
Mr. Stein joined Dentons as Counsel in 2014 after serving
as Counsel at Heenan Blaikie LLP from 2008 until February 2014. From 1994 to 2008, he was a senior
executive with Magna International Inc. ("Magna") reporting to the
Chairman, Frank Stronach and
continued to act as a consultant reporting to the Executive
Vice-Chairman until November 2010.
Prior to becoming a consultant, Mr. Stein held the position of
Senior Vice-President of Corporate Affairs at Magna. Before joining
Magna, he was Senior Corporate Counsel for Toyota Canada and Toyota
Credit Canada. Mr. Stein has been a board member of various
publicly listed companies.
"On behalf of the Invictus, I want to thank Mr. Dixon and
Mr. Hocher for their hard work and dedication to the Company. As
founder of Acreage Pharms in 2013, Trevor has played an integral
role in Invictus' growth strategy and will continue to oversee the
expansion of the Acreage Pharms' facility and its EU-GMP
certification," said Mr. Kveton. "I am thrilled to welcome Mr.
Stein to the Board, his wealth of business acumen and experience
across a wide range of industries in Canada and abroad will be a great asset to
support the executive team and fellow Directors in executing on the
Company's vision."
For more information, please visit
www.invictus-md.com.
On Behalf of the Board,
George E.
Kveton
Chief Executive Officer and
Director
Jessica
Martin
Vice President, Public Relations and
Regulatory Affairs
(833) 879-4363
About Invictus
Invictus is a global cannabis company offering a selection
of products under a wide range of brands. Our integrated sales
approach is defined by five pillars of distribution including
medical, adult-use, international, Licensed Producer to Licensed
Producer and retail stores.
Invictus has partnered with business leaders to convey our
corporate vision, including KISS music legend and business mogul
Gene Simmons as our Chief Evangelist
Officer. To meet growing demand, Invictus is expanding its
cultivation footprint, with three cannabis production facilities
licensed under the Cannabis Act and Cannabis Regulations in
Canada. To accommodate
international sales, Invictus' wholly-owned subsidiary, Acreage
Pharms Ltd. ("Acreage Pharms"), has designed and is currently
building its Phase 3 purpose-built cultivation facility to be
European Union Good Manufacturing Practices ("EU-GMP") compliant.
The Company is targeting up to 50 percent of production to medical
cannabis. To ensure consistency in quality and supply, Invictus
maintains all aspects of the growing process through its
subsidiary, Future Harvest Development Ltd. ("Future Harvest"), a
high-quality fertilizer and nutrients manufacturer. Invictus drives
sustainable long-term shareholder value through a diversified
product portfolio with over 70 Health Canada approved strains and a
multifaceted distribution strategy including medical, adult-use,
international, Licensed Producer to Licensed Producer and retail
stores. For more information visit www.invictus-md.com.
Neither the Canadian Securities Exchange nor its
Regulation Services Provider accepts responsibility for the
adequacy or accuracy of this release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/keith-stein-replaces-trevor-dixon-and-josef-hocher-on-invictus-board-300778282.html
SOURCE Invictus MD Strategies